Track upcoming PDUFA dates, clinical trial readouts, and FDA advisory committees across 25+ biotech catalysts. Click any catalyst to view full details, dilution risk, and related signals.
FDA catalysts are regulatory events that can significantly impact biotech stock prices. The most important catalyst types include PDUFA dates (Prescription Drug User Fee Act deadlines), AdCom meetings (FDA Advisory Committee meetings), and clinical trial readouts (Phase 1, 2, and 3 data releases).
BiotechSign tracks all upcoming catalysts across 800+ biotech and pharmaceutical companies, providing real-time monitoring of FDA decisions, insider trading activity, dilution risk, and more. Use this page to identify upcoming catalysts and click through to individual pages for detailed analysis.
Not financial advice. Biotech investing involves binary FDA outcomes that can result in total loss. Data by Guerilla Finance Inc. for informational purposes only. Always conduct your own due diligence.